Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline have?

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline has 182 citations in the OpenAlex counts ScholarIQ stores.

When was Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline published?

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline has 2020 year in the ScholarIQ index.

What is the open-access status of Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline?

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline has bronze oa status in the ScholarIQ index.

What is the DOI of Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline?

The DOI for Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline is on the source record.

What is the PMID of Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline?

The PMID for Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline is on the source record.

What is the OpenAlex record for Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline?

The OpenAlex for Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline is on the source record.